February 3, 2026 10:52am

Proceeds are estimated at $25 M

SGMO closed <Monday> at $0.5679 and is trading at -$0.1413 or -24.74% to $0.44

Cantor and Wells Fargo Securities are acting as joint book-running managers for the offering.

The offering consisting of 35,190,292 shares of its common stock and pre-funded warrants to purchase 17,787,033 shares of its common stock, together with accompanying warrants to purchase 52,977,325 shares of its common stock.

The Bottom Line: Saved by the filing of paper …

  • The combined offering price of each share of common stock and accompanying warrant is $0.4719.

Some stats … needed cash and more, I’d also say a .... reverse of shares???

  • Present cash: $29.62 M
  • Debt: $25.42 M
  • Shares outstanding: 336.49 M
  • Float: 329.13 M shares
  • Held by institutions: 18.70%
  • Shares short: 20.92%
  • Short % of float: 6.27%

One key is the combined offering price of each pre-funded warrant and accompanying warrant is $0.4619.

  • The common stock and pre-funded warrants are being sold in combination with an accompanying warrant to purchase one share of common stock issued for each share of common stock or pre-funded warrant sold. The accompanying warrant has an exercise price of $0.4719 per share, will become exercisable six months from the date of issuance and will expire 5 and 1/2 years from the date of issuance.
  • In addition, Sangamo agreed to reduce the exercise price on outstanding warrants to purchase 23,809,523 shares of common stock held by an investor from $1.00 to $0.4719 and extend the term of such warrants.

 

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice. Whether information or intelligence is good, bad, or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor, and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication. Regulation Analyst Certification (Reg AC):

The research analyst primarily responsible for the content of this report certifies the following under Reg AC: I hereby certify that all views expressed in this report accurately reflect my personal views about the subject company or companies and it’s or their securities. I also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report.